Difference of genetic polymorphisms in patients with type 2 diabetes mellitus with absence or presence of chronic heart failure with preserved ejection fraction

Cover Page

Cite item

Full Text

Abstract

Background. It is important to note a close comorbidity of type 2 diabetes mellitus (DM2) and cardiovascular issues, in particular, chronic heart failure (CHF) among the elderly patients. Research of predisposing genes’ polymorphisms allows to connect genotype particularities with the development of such conditions.

Aim. Identify genetic polymorphisms in patients with DM2 and CHF with preserved ejection fraction.

Materials and methods. Polymorphisms of genes of folate cycle, metabolism, hemostasis, neurohumoral status were studied in 106 patients (age 69.7±10.1 years) with DM2 and hypertension with and without CHF.

Results. In patients with DM2 without CHF, the frequency of polymorphisms of these genes is comparable to the population. There are MTHFR: 677 C>T, MTR: A2756G, ITGB3: T1565C, PAI-1: -675 5G>4G, NOS3: -786 T>C, PPARG: C1431T was found in patients with DM2 and CHF, a statistically significant increase in the frequency of gene polymorphisms was found, compared with patients with DM2 without CHF.

Conclusion. The identified polymorphisms in patients with type 2 diabetes and CHF with preserved LV ejection fraction are associated with such phenotypic manifestations as: a tendency to thrombophilia, realized through a violation of homocysteine, vascular tone and trophism, immune response, as well as the oxidation of free fatty acids and the activation of the inflammation process.

About the authors

Tatiana S. Sveklina

Kirov Military Medical Academy

Author for correspondence.
Email: Sveklinats@mail.ru
ORCID iD: 0000-0001-9546-7049

Cand. Sci. (Med.), Assoc. Prof.

Russian Federation, St. Petersburg

Sergey B. Shustov

Kirov Military Medical Academy

Email: editor@omnidoctor.ru
ORCID iD: 0000-0002-9075-8274

D. Sci. (Med.), Prof.

Russian Federation, St. Petersburg

Svetlana N. Kolyubaeva

Kirov Military Medical Academy

Email: editor@omnidoctor.ru
ORCID iD: 0000-0003-2441-9394

D. Sci. (Biol.)

Russian Federation, St. Petersburg

Alexei N. Kuchmin

Kirov Military Medical Academy

Email: editor@omnidoctor.ru
ORCID iD: 0000-0003-2888-9625

D. Sci. (Med.), Prof.

Russian Federation, St. Petersburg

Vadim A. Kozlov

I.N. Ulyanov Chuvash State University

Email: editor@omnidoctor.ru
ORCID iD: 0000-0001-7488-1240

D. Sci. (Biol.), Cand. Sci. (Med.)

Russian Federation, Cheboksary

Yrii Sh. Halimov

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: editor@omnidoctor.ru
ORCID iD: 0000-0002-7755-7275

D. Sci. (Med.), Prof.

Russian Federation, Saint Petersburg

Vladislav V. Konyaev

Kirov Military Medical Academy

Email: editor@omnidoctor.ru

Student

Russian Federation, St. Petersburg

References

  1. Seferović PM, Petrie MC, Filippatos GS, et al. Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20(5):853–72. doi: 10.1002/ejhf.1170
  2. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241(19):2035–8. doi: 10.1001/jama.241.19.2035
  3. Ašić A, Salazar R, Storm N, et al. Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina. Croat Med J. 2019;60(3):212–20. doi: 10.3325/cmj.2019.60.212
  4. Hermans MP, Gala JL, Buysschaert M. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with type 2 diabetes. Diabet Med. 2006;23(5):529–36. doi: 10.1111/j.1464-5491.2006.01841.x
  5. Zhong JH, Rodríguez AC, Yang NN, Li LQ. Methylenetetrahydrofolate reductase gene polymorphism and risk of type 2 diabetes mellitus. PLoS One. 2013;8(9):e74521. doi: 10.1371/journal.pone.0074521
  6. Jusić-Karić A, Terzić R, Jerkić Z, et al. Frequency and association of 1691 (G>A) FVL, 20210 (G>A) PT and 677 (C>T) MTHFR with deep vein thrombosis in the population of Bosnia and Herzegovina. Balkan J Med Genet. 2016;19(1):43–50. doi: 10.1515/bjmg-2016-0006
  7. Settin A, El-Baz R, Ismaeel A, et al. Association of ACE and MTHFR genetic polymorphisms with type 2 diabetes mellitus: Susceptibility and complications. J Renin Angiotensin Aldosterone Syst. 2015;16(4):838–43. doi: 10.1177/1470320313516172
  8. Kahleová R, Palyzová D, Zvára K, et al. Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins. Am J Hypertens. 2002;15(10 Pt 1):857–64. doi: 10.1016/s0895-7061(02)02984-9
  9. Ruiz-Cosano J, Torres-Moreno D, Conesa-Zamora P. Influence of polymorphisms in ERCC5, XPA and MTR DNA repair and synthesis genes in B-cell lymphoma risk. A case-control study in Spanish population. J BUON. 2013;18(2):486–90. PMID: 23818366
  10. Helmer P, Damm E, Schiekofer S, et al. β3-integrin Leu33Pro gain of function variant does not modulate inflammatory activity in human derived macrophages in diabetes. Int J Med Sci. 2021;18(12):2661–5. doi: 10.7150/ijms.55648
  11. Свеклина Т.С., Шустов С.Б., Колюбаева С.Н., и др. Генетические маркеры хронической сердечной недостаточности с сохраненной фракцией выброса. Современные проблемы науки и образования. 2021;(3):111 [Sveklina TS, Shustov SB, Kolyubaeva SN, et al. Genetic markers of chronic heart disease insufficiency with a preserved ejection fraction. Modern Problems of Science and Education. 2021;(3):111 (In Russian)]. doi: 10.17513/spno.30769
  12. Raina P, Sikka R, Gupta H, et al. Association of eNOS and MCP-1 genetic variants with type 2 diabetes and diabetic nephropathy susceptibility: A case-control and meta-analysis study. Biochem Genet. 2021;59(4):966–96. doi: 10.1007/s10528-021-10041-2
  13. Abdullayeva ChA, Karimov KhYa, Kamilova UK, et al. The NOS3 T-786C (rs2070744) gene polymorphism in patients of Uzbek nationality with chronic heart failure. International Journal of BioMedicine. 2014;4(4)(Suppl 1):S12–4.
  14. Bayramoğlu1A, Bayramoğlu G, Güler HI. The role of rs1799889 genetic variation in type 2 diabetes and diabetic nephropathy risk. Erciyes Med J. 2020;42(4):441–6. doi: 10.14744/etd.2020.04378
  15. Курбанов Р.Д., Срожидинова Н.З. Значение PRO12ALA полиморфизма гена PPARγ при артериальной гипертонии и метаболическом синдроме. Евразийский кардиологический журнал. 2012;(2):47–54 [Kurbanov RD, Srojidinova NZ. Role of the PPARγ PRO12ALA polymorphism in hypertension and metabolic syndrome. Eurasian Heart Journal. 2012;(2):47–54 (In Russian)]. doi: 10.38109/2225-1685-2012-2-47-54
  16. Chrysant SG, Chrysant GS. The current status of homocysteine as a risk factor for cardiovascular disease: A mini review. Expert Rev Cardiovasc Ther. 2018;16(8):559–65. doi: 10.1080/14779072.2018.1497974
  17. Мухина П.Н., Воробьева Н.А., Белякова И.В. Генетические полиморфизмы метилентетрагидрофолатредуктазы и их влияние на уровень гомоцистеина плазмы крови и на отдаленные результаты течения острого инфаркта миокарда. Экология человека. 2012;19(10):54–60 [Mukhina PN, Vorobyova NA, Belyakova IV. Genetic polymorphysm in the gene of methyltetrahydrofolatreductaza and its impact on plasma homocysteine level and on long-term effects of acute myocardial infarction. Ekologiya Cheloveka. 2012;19(10):54–60 (In Russian)]. doi: 10.17816/humeco17427
  18. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115(10):1285–95. doi: 10.1161/CIRCULATIONAHA.106.652859
  19. Galasso G, Santulli G, Piscione F, et al. The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. BMC Cardiovasc Disord. 2010;10:41. doi: 10.1186/1471-2261-10-41
  20. Shirazi LF, Bissett J, Romeo F, Mehta JL. Role of inflammation in heart failure. Curr Atheroscler Rep. 2017;19(6):27. doi: 10.1007/s11883-017-0660-3

Copyright (c) 2023 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies